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Abstract
Background:  Several studies have shown cross-sectional associations between long term
exposure to particulate air pollution and survival in general population or convenience cohorts.
Less is known about susceptibility, or year to year changes in exposure. We investigated whether
particles were associated with survival in a cohort of persons with COPD in 34 US cities,
eliminating the usual cross-sectional exposure and treating PM10 as a within city time varying
exposure.
Methods: Using hospital discharge data, we constructed a cohort of persons discharged alive with
chronic obstructive pulmonary disease using Medicare data between 1985 and 1999. 12-month
averages of PM10 were merged to the individual annual follow up in each city. We applied Cox's
proportional hazard regression model in each city, with adjustment for individual risk factors.
Results: We found significant associations in the survival analyses for single year and multiple lag
exposures, with a hazard ratio for mortality for an increase of 10 μg/m3 PM10 over the previous 4
years of 1.22 (95% CI: 1.17–1.27).
Conclusion: Persons discharged alive for COPD have substantial mortality risks associated with
exposure to particles. The risk is evident for exposure in the previous year, and higher in a 4 year
distributed lag model. These risks are significantly greater than seen in time series analyses.
Background
Worldwide studies have shown the short-term effect of
particulate pollution (PM) on hospital admissions and
deaths from respiratory causes [1-6].
Epidemiologic studies indicate that hospitalizations for
respiratory causes are strongly related to PM exposure.
Several hypotheses have been advanced for possible
underlying mechanisms [7]. For example, PM may impair
ventilation in COPD patients by causing airway narrow-
ing and increasing the work of breathing [8]. In addition
some particles can cause epithelial cell damage, pulmo-
nary edema, and eventually fibrosis [9].
Particles may be deposited in the extra thoracic airways
(mouth, nose, larynx), in airways of the trachiobronchial
regions and in the alveolar region where the gas exchange
occurs [10].
The respiratory tract deposition patterns depend on parti-
cle size and distribution within the inspired air. Biologic
effects may be a function also of particle number, compo-
sition and the total surface area of the particle.
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Various factors have been shown to influence particle dep-
osition, such as age, ventilation patterns and the presence
of obstructive or inflammatory airway disease [11].
Higher ventilation increases total deposition, and
obstructive airway disease, such as chronic bronchitis,
emphysema and asthma results in increased deposition in
the lower respiratory tract [12].
Retention of particles is a function of deposition site and
clearance of particles, which again may be impaired in
persons with COPD. Chronic effects may also arise from
recurring cycles of pulmonary injury and repair [10]. Stud-
ies have shown that high doses of particles can trigger oxi-
dative stress and the induction of inflammation, increased
blood coagulation, impaired cellular defence, and modu-
lation of the immune system [13,14].
The effect of longer term PM exposure on survival in gen-
eral cohorts has been examined in a number of studies,
which mainly focused on total or cardiovascular mortal-
ity. The Harvard Six Cities prospective cohort study [15]
showed an association between cardiovascular mortality
and chronic exposure to air pollutants. Other studies
[16,17] such as the American Cancer Society Cancer Pre-
vention study population, most recently[17] reported an
association between long term average PM and specific
causes of death, such as deaths from all cardiovascular dis-
ease plus diabetes, ischemic heart disease, and dysrhyth-
mias, heart failure, and cardiac arrest mortality.
Another cohort in seven French cities [18] found that
urban air pollution was associated with increased total
mortality over 25 years, and they also observed a consist-
ent pattern for lung cancer and cardiopulmonary causes.
While these previous studies have reported an association
of air pollution with survival, and sometimes cause spe-
cific survival, these have not examined whether risk
changed with annual changes in exposure.
Specifically, in most published cohort studies, the expo-
sure was taken to be long term differences in air pollution
concentrations across geographic location, which does
not allow examination of whether changes in annual
exposure result in changes in risk. However, a recent study
in Dublin [19] suggests that decreasing air pollution con-
centrations by a sudden intervention (a coal ban) reduced
cardiovascular and respiratory deaths the next year, with
no further decrease in subsequent years.
This suggests a cohort study with PM10 treated as a time
varying covariate, with annual follow-up periods for expo-
sure and survival, would be of considerable interest. In
addition, if such studies are done within city, then by
design, they eliminate the possibility of confounding by
unmeasured covariates that vary across city or geography.
A recent re-analysis of the Harvard Six Cities Study, which
extended the mortality follow-up period, used annual
PM2.5 as a time-varying exposure, and found a significant
association of PM2.5 with mortality, and moreover that
most of the effect was with the previous two year's expo-
sure [20]. However, in that study, variations in exposure
both between city and between years within city contrib-
uted to the exposure gradient.
Another recent study investigated [21] whether year-to-
year within city changes in annual PM exposure were asso-
ciated with progression of disease or reduced survival in a
study of 196,000 persons discharged alive following an
acute myocardial infarction. We have applied that
approach in a 34-city cohort study, with cohorts defined
within each city by hospital discharge for COPD.
The focus of this study is therefore to examine the effect of
exposure to particulate air pollution on persons dis-
charged alive following an admission for chronic obstruc-
tive pulmonary disease (COPD).
Methods
Study Population
Using Medicare data for persons aged 65 and older for the
years 1985 to 1999, we constructed a cohort of survivors
with a specific condition we hypothesized might render
subjects at greater risk, defining cases as an emergency
admission for a primary or secondary discharge diagnosis
of chronic obstructive pulmonary disease (COPD, ICD-9:
490–496, except 493); we excluded subjects who died
within three months of their admission.
Medicare data provide also the date of death for those sub-
jects who die, and therefore we could define whether they
were still alive as of the end of 1999; the date of death field
is derived from the Medicare enrolment database and
cross-referenced with the Social Security Administration's
Master Beneficiary Record [22].
Medicare provide also information on age, gender, race,
number of coronary and medical intensive care days, and
on factors that might modify the risk of survival, such as
primary or secondary diagnoses of atrial fibrillation (ICD-
9: 427.3), myocardial infarction (MI, ICD-9:410), diabe-
tes (ICD-9: 250), congestive heart failure (CHF, ICD-9:
428), and essential hypertension (ICD-9: 401) on previ-
ous admissions, or whether these were noted as secondary
diagnoses on the index admission. We defined a categori-
cal variable for type of COPD based on ICD codes (ICD-
9: 491,492,496).Environmental Health 2008, 7:48 http://www.ehjournal.net/content/7/1/48
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Subjects alive the first of January of the year following the
admission were entered into the cohort, and follow-up
periods were calendar years. We excluded subjects whose
death or subsequent admission occurred within the first
three months of their index admission, and those who
were admitted in 1999.
During the years 1985 to 1999 survival may have
improved due to changes in therapy, underlying disease
state, etc. To control for these changes, we used strata to
allow a different underlying hazard for each 5-year inter-
val in the study.
City characteristics as population density, percentage of
population with central air conditioning, and percentage
of population 65 and older with income > $50,000 were
obtained from the 1990 United States census [23]; the
average annual mortality rates for emphysema among
people = 65 years old were obtained from the National
Center for Health Statistics.
Environmental Data
We obtained PM10 (particulate air matter with aerody-
namic diameter less than 10 μm) data from US Environ-
mental Protection Agency's Aerometric Information
Retrieval System [24] for the years 1985 to 1999.
We selected thirty-four cities with daily monitoring of par-
ticulate matter and representing a geographic distribution
across the country (Figure 1).
When more than one monitor was available in one
county, PM10  was averaged over the county using a
method previously described [25,26]. Briefly, we com-
puted local daily mean concentrations using an algorithm
that accounts for the different monitor-specific means and
variances. However, before averaging, any monitor that
was not well correlated with the others (r<0.8 for 2 or
more monitor pairs within a community) was excluded as
it likely measured a local pollution source and would not
represent the general population exposure over the entire
community.
For each subject and follow-up period we created yearly
averages (January-December) of pollution for that year
and up to the 3 previous years.
PM10 was then treated as a time varying covariate in the
survival analysis.
Statistical Methods
To define the cohort we assumed that each subject entered
the cohort if he/she survived at least 3 months and was
alive on the first January of the year following the admis-
sion. For each subject the follow up periods were 1 year
Map of the USA with the state boundaries and the cities analyzed in the study Figure 1
Map of the USA with the state boundaries and the cities analyzed in the study.
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periods (January – December) until the year in which they
die (failure) or until December 1999 (censoring). This
method has been previously described [21].
We analyzed the data with an extended Cox's propor-
tional hazard regression model (Proc PHREG in SAS [27]
which allow for time-varying covariates in survival analy-
sis [28], as previously described [21].
We controlled for individual risk factors such as age, gen-
der, race, season of admission, number of days of coro-
nary and medical intensive care, previous diagnoses for
atrial fibrillation and MI, and secondary or previous diag-
noses for diabetes, CHF, and hypertension, time period,
and season.
Season of the index discharge that defined entry into the
cohort was defined as: cold (December through Febru-
ary), hot (June through August), and transitional. To
allow for possible non-proportionality of the survival
rates, time period (3 categories, one for each 5 year incre-
ment), age (5 year categories), gender, race (white, black,
others), and type of COPD were treated as stratification
variables.
To control for tied observations we used the appropriate
likelihood function as given by Kalbfleisch and Prentice
[29].
In the second stage of the analysis, the city specific results
were combined using a random effect meta-regression
[30]. To be conservative we report the results incorporat-
ing a random effect, whether or not there was significant
heterogeneity.
We examined effect modification by city characteristics by
entering them as predictor variables in the meta-regres-
sion. These included measures of socio-economic condi-
tion (percent of persons 65 and older with income >
$50,000), exposure related measures (mean PM10 in the
city), general social factors (population density), and the
emphysema death rate in persons aged 65 and older as a
surrogate for the smoking history of the population.
We also examined effect modification by age group (65–
75 vs 76 and over), race (white vs other), and sex by
including the interaction terms between the yearly PM10
and each variable in the model.
For each subject in each follow-up period, we considered
the following possible exposure indexes: the average PM10
in their city in that follow-up period, and a model con-
taining simultaneously the exposure during the follow-up
period and each of the three previous years (distributed
lag), to see if we could determine how the PM effect
dropped off over time. We also computed the sum of the
PM10 effect from lag 0 to the three previous years. The
results are expressed as Hazard ratio (HR) for a 10 μg/m3
increment of PM10.
Results
Figure 1 shows a map of the USA with the state bounda-
ries and the cities analyzed in the study.
Table 1 shows characteristics of the study population;
among the 34 cities there was a higher percentage of
female, and of whites, with a mean age of 76 years.
During the study period there were 1,039,287 hospital
discharges with COPD; of these, 57% died before the end
of follow-up.
The average duration of the follow-up was 4.5 years with
the range of survival times between 1 to 14 years.
The most common type of COPD was chronic airway
obstructions (55%); 14% of cases had chronic bronchitis,
and 8% had emphysema.
Figure 2 presents the box-plots of the of the individually
assigned 1-year PM10 mean in each city, ordered by con-
Table 1: Characteristics of the study population for the chronic 
obstructive pulmonary disease cohort, among residents of 34 US 
cities
N* %
Events 1039 100
Deaths 593 57.1
Gender
Male 494 47.5
Female 546 52.5
Race
White 860 82.8
Black 122 11.7
Other 57 5.5
Age** 76.4 (66.2–89.6)
N days in coronary care** 0.35 (0–2.3)
N days in intensive care** 0.72 (0–4.2)
Secondary or previous diagnoses:
CHF 205 19.7
Diabetes 133 12.8
Hypertension 287 27.6
Previous admissions:
Atrial fibrillation 67 6.4
MI 38 3.7
COPD type
Chronic bronchitis 179 13.9
Emphysema 108 8.4
Chronic airway obstructions 706 55.2
* N divided by 1000.
** Expressed as Mean (5%–95%)Environmental Health 2008, 7:48 http://www.ehjournal.net/content/7/1/48
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Boxplots of the of the individually assigned 1-year PM10 mean in each city; years 1986–1999 Figure 2
Boxplots of the of the individually assigned 1-year PM10 mean in each city; years 1986–1999.
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centration of PM10. Los Angeles has the highest concentra-
tions level, while Honolulu the smallest. The average
PM10 across all cities was 29.4 μg/m3.
To test the adequacy of the 5 year strata to control for sec-
ular changes in survival, we computed the annual death
rate by year in the cohort (Table 2). These were higher in
the first five years but changed little during the following
years.
Table 3 presents the results of the PM10 analyses. The
results are expressed as Hazard Ratio (HR) for 10 μg/m3 of
PM10. We found significant associations in the analyses
adjusting for confounders, with a HR of 1.11 (95% CI:
1.06–1.15) for 10 μg/m3 increase in PM10the same year.
Figure 3 shows the city specific results for PM10 at lag 0. In
most cities we found positive and significant associations.
When looking at the sum of the effects of PM exposure on
the four years (same year and 3 preceding years) in the dis-
tributed lag model we found a hazard ratio for mortality
of 1.22 (95% CI: 1.17–1.27). The PM10 effect sizes were
higher in the distributed lag model than in the model with
a single exposure period. When looking by lag, the effect
on mortality risk in each year of follow-up was lower for
exposure in the same year, higher for the exposure in the
two previous years, and lower again for exposure three
years earlier.
In the second part of the analysis we tried to explain the
observed heterogeneity among cities by looking at effect
modification. We used a meta-regression to examine sev-
eral potential predictors. The results of these analyses are
presented in Table 4. PM10 effect size was uncorrelated
with the emphysema death rate, therefore implying that
cigarette smoking did not appear to confound the associ-
ation.
There was little indication of effect modification by any of
the examined variables.
Finally we examined effect modification by age group
(65–75 = 0 vs 76 and over = 1), race (white = 0 vs other =
1), and sex (male = 0, female = 1). The results are pre-
sented in Table 5. We found significant interactions, with
a higher effect in the older age group, in non-white sub-
jects, and in males.
Discussion
We found a significant effect of long-term exposure to air-
borne particles on the risk of death in a large multi-city
study of elderly subjects discharged alive following an
admission for COPD, with a relatively large effect size
compared to general population cohorts previously
reported. We also found that the effect was not limited to
the exposure in the each year of follow-up, with larger
cumulative effects spread over the follow-up year and 3
preceding years.
This study is comparable to a similar study which ana-
lyzed admissions for myocardial infarction. That study
investigated whether PM was associated with progression
of disease or reduced survival in a study of 196,000 per-
sons from 21 US cities discharged alive following an acute
myocardial infarction, and found a significant effect of
long term exposure to airborne particles on the risk of
death, progression to heart failure and to a subsequent MI
and that association persisted for several years of lag, but
was falling off by lag 3 [21].
This is the first long-term study which investigated per-
sons discharged from the hospital for COPD. One key fea-
ture of this study compared to many previously published
air pollution cohort studies is that it is population based,
rather than based on a convenience sample in each city.
This is an important distinction. While individual expo-
sures differ from the mean exposure in each city in each
Table 2: Overall Mortality Rates across all cities by year
Year Mortality rates
1986 0.20
1987 0.18
1988 0.16
1989 0.15
1990 0.14
1991 0.13
1992 0.13
1993 0.12
1994 0.12
1995 0.13
1996 0.12
1997 0.12
1998 0.12
1999 0.12
Table 3: Hazard Ratio (HR) and 95% Confidence Interval (CI) for 
10 mg/m3 increase in PM10 for the year of failure and for the 
distributed lag from the year of failure up to 3 previous years, 
across the 34 cities
HR 95% CI P-values
PM10 annual 1.11 1.06 1.15 0.000
Distributed lag model
Lag 0 1.03 1.00 1.07 0.046
Lag 1 1.06 1.03 1.10 0.000
Lag 2 1.07 1.05 1.09 0.000
Lag 3 1.03 1.01 1.05 0.001
Sum lags 0–3 1.22 1.17 1.27 0.000Environmental Health 2008, 7:48 http://www.ehjournal.net/content/7/1/48
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year, it seems reasonable to assume that the exposure error
is Berkson, and produced no downward bias in the esti-
mated effect [31]. That is, each person's exposure fluctu-
ates randomly around the population average exposure, a
situation that reduces power, but produces no bias in
effect estimates. In contrast, for a convenience sample
cohort, such as the ACS study, this is less clear, since they
do not capture either the population average mortality
City specific results: Hazard Ratio (HR) for 10 μg/m3 of PM10 Figure 3
City specific results: Hazard Ratio (HR) for 10 μg/m3 of PM10.
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Table 4: Modification of the PM10 association by city characteristics across 34 US cities
City HR at the 25% Percentile HR at the 75% Percentile
Characteristics P-value for modifier 1st Quartile HR 95% CI 3rd Quartile HR 95% CI
Percent population aged 65+ in poverty status
0.56 1.4 1.12 1.06 1.18 2.7 1.10 1.05 1.15
Annual mortality rate for emphysema in 65+
0.19 29.5 1.09 1.04 1.14 46.9 1.12 1.07 1.17
PM10 from traffic
0.27 2.3 1.12 1.07 1.18 5.0 1.09 1.05 1.14
Air Conditioning
0.77 26.0 1.11 1.06 1.17 67.0 1.10 1.04 1.16
Population density
0.09 670.0 1.13 1.08 1.18 2344.1 1.11 1.07 1.16
Medium income
0.26 4.3 1.13 1.07 1.18 5.6 1.10 1.05 1.14
Mean summer app temperature
0.91 21.6 1.11 1.06 1.16 26.3 1.10 1.05 1.16
Variance of summer temperature
0.84 11.0 1.10 1.04 1.16 21.4 1.11 1.05 1.17
Results are expressed as Hazard Ratio (HR) and 95% Confidence Interval (CI) for 10 mg/m3 increase in PM10 (distributed lag) estimated at the 25th 
percentile and the 75th percentile of the effect modifierEnvironmental Health 2008, 7:48 http://www.ehjournal.net/content/7/1/48
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experience in the city or the population average exposure.
The ACS volunteers in city A may represent a healthier,
and less exposed subset of city A then they do in city B.
This, clearly, can introduce bias into the estimates.
Another key difference is the focus on shorter term, within
city differences in exposure. Demonstrating that effects
can be seen within a few years of exposure changes has
important implications for health impact assessments. If
changes in risk induced by particle exposure were perma-
nent, we would have to wait decades to see public health
improvements following changes in exposure. These
results indicated that they should be seen rather within
years.
The relative risks of mortality for all our four outcomes are
higher than has been reported in general population stud-
ies such as the six city study (RR = 1.088, 95% CI: 1.03–
1.13)[32]. This may be due to the focus on the elderly,
however previous studies have not suggested such large
differences in risk due to age alone, and the restriction to
subjects with chronic diseases thought to increase suscep-
tibility likely plays a role in the increased effect size. Our
risks are also higher than the one observed in short term
effect studies, for example our hazard ration for the same
year (1.11 (95% CI: 1.06–1.15)) is higher than the previ-
ous published result of 14 US cities [6] reporting a RR of
1.02 (95% CI: 1.01–1.02) for exposure in the few days
preceding a death.
Another difference between this study and previous
cohort studies is the source of variation in exposure. In
this study the basic analysis was conducted within city,
and exposure variation comes from temporal changes in
pollution concentration. In the other cohort studies, the
source of exposure variation is across geographic area. For
example the American Cancer Society study [17] con-
trasted covariate adjusted survival in each city with long
term average pollution in that city. To the extent that geo-
graphic variations in unmeasured confounders such as
diet, usual treatment for medical conditions, etc exist as
potential confounders to those studies, that problem is
obviated in our study design. Instead, we must contend
with unmeasured temporal confounding. We have used
separate strata within each city for 5 year intervals to cap-
ture such changes, but as with any study, this may be
imperfect control. Nevertheless, the finding of an associa-
tion between longer term exposure to airborne particles
and survival in a study with such different susceptibilities
to confounding adds considerable strength to the evi-
dence of a much larger effect of longer term exposure to
particles on mortality risk.
The use of longitudinal rather than cross-sectional expo-
sure gradients in this study may also explain some of the
differences in effect size estimates, as the variation in cen-
tral station monitoring and personal exposure over time
may be more correlated than similar variations over space.
In addition, the American Cancer Society study used mon-
itors within the multi-counties metropolitan areas to
assign exposure, whereas our subjects are generally
matched to monitors in the same city or county. A recent
re-analysis of the American Cancer Society study restricted
to subjects living in the same county as the monitor
reported a higher relative risk [33].
This study presents some limitations; one is that Medicare
does not provide the underlying cause of death, limiting
our ability to study susceptibility.
The main limitation, however, is the absence of informa-
tion on subject characteristics such as smoking, body mass
index, or medicine use. In our model we controlled for all
the available personal characteristics such as age, race,
gender, severity of the index admission, and detailed data
on previous and secondary diagnosis. Moreover, we con-
ducted a city-specific analysis to remove location-specific
differences from the analyses. Hence differences across cit-
ies in smoking rates, etc cannot confound the association,
as only the temporal variability in pollution within city
contributes to the association. We do not believe year to
year changes in PM10 concentrations are correlated with
year to year changes in smoking rates within city, but we
cannot definitively exclude the possibility. Further, the
emphysema death rate in persons aged 65 and older,
which is strongly associated with smoking history, did not
modify the PM associated risk.
Conclusion
Our findings suggest that long-term exposure to particu-
late matter elevates the risk of mortality in susceptible
population defined by COPD admissions. The finding
that the effect seems increasing to the preceding two years
of exposure has important implications for public health.
It indicates that reductions in air pollution should be fol-
lowed quickly by improvements in public health, rather
Table 5: Hazard Ratio (HR) and 95% Confidence Interval (CI) for 
10 μg/m3 increase in PM10 for the interaction between PM10 and 
age race and sex
HR 95% CI
young 1.11 1.085 1.128
old 1.14 1.119 1.164
female 1.10 1.080 1.130
male 1.15 1.122 1.178
other race 1.23 1.194 1.271
white 1.12 1.099 1.141Environmental Health 2008, 7:48 http://www.ehjournal.net/content/7/1/48
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than the decades some have suggested. This is in accord-
ance with some other recent studies [20,21,34], and
heightens the urgency for such measures.
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